From GlobeNewswire: 2025-04-17 05:00:00

Oculis Holding AG, a global biopharmaceutical company, collaborates with EURETINA to announce the 2025 Ramin Tadayoni Award, honoring Professor Tadayoni’s legacy in retinal research. The award offers €30,000 for research support and €5,000 for the candidate, accepting applications until May 12, 2025, with the winner announced at the EURETINA Congress in Paris on September 4 – 7, 2025. Last year’s recipient, Dr. Andrea Govetto, is developing a computational model for macular edema treatment. Oculis CEO Riad Sherif and EURETINA President Anat Loewenstein express gratitude for the award’s continuation in honor of Prof. Tadayoni’s impactful contributions to ophthalmology.



Read more at GlobeNewswire: Oculis and EURETINA Announce the 2025 Ramin Tadayoni Award